Core One Labs Inc. (COOL) | WebDisclosure

Basculer en Français

8227	Companies
111057	Keywords
52775	Articles
60952	Press releases

Home
Companies
Core One Labs Inc.

BRIEF

published on 07/09/2024 at 01:20, 3 months 30 days ago

Core One Labs Enters into Loan Agreement with Right Season Investments

Loan Agreement Psychedelic Medicines Core One Labs Right Season Investments Psilocybin Production
BRIEF

published on 07/09/2024 at 01:20, 3 months 30 days ago

Core One Labs conclut un accord de prêt avec Right Season Investments

Accord De Prêt Laboratoires Core One Investissements De Bonne Saison Médicaments Psychédéliques Production De Psilocybine
PRESS RELEASE

published on 07/09/2024 at 01:15, 3 months 30 days ago

Core One Enters into Loan Agreement with Right Season Investments
Core One Labs Inc. secures CDN$300,000 loan from Right Season Investments Corp. for working capital. Company focuses on developing psychedelic medicines and innovative delivery systems

Loan Agreement Working Capital Core One Labs Inc. Psychedelic Medicines Biotechnology Research
PRESS RELEASE

published on 12/09/2023 at 00:55, 10 months 30 days ago

Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market
PRESS RELEASE

published on 12/02/2023 at 01:00, 11 months 6 days ago

Core One Labs’ Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer’s and Parkinson’s, Showing Potential to Outperform Current Treatment Methods
Core One Labs Inc. ('Core One') shares exciting results of Stage 2 animal model studies on Akome's five plant bioactives and DMT, demonstrating potential to outperform current treatment methods for Alzheimer's and Parkinson's. Research team to investigate elevated concentration levels of Bio-Compounds in further studies

Core One Labs Inc. Akome Stage 2 Animal Model Studies Bio-compounds Alzheimer's And Parkinson's
PRESS RELEASE

published on 08/05/2023 at 01:25, 1 year 3 months ago

Core One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer’s and Parkinson's Disease
PRESS RELEASE

published on 08/02/2023 at 01:55, 1 year 3 months ago

Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass
PRESS RELEASE

published on 07/29/2023 at 01:25, 1 year 3 months ago

Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer’s and Parkinson’s Disease
PRESS RELEASE

published on 07/22/2023 at 00:55, 1 year 3 months ago

Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic Compounds
PRESS RELEASE

published on 07/12/2023 at 01:25, 1 year 3 months ago

Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin

Accesswire

Published on 11/08/2024 at 13:05, 6 minutes ago

Aton Announces Corporate and Operations Update
Published on 11/08/2024 at 13:00, 11 minutes ago

Honey Badger Announces Change of Transfer Agent
Published on 11/08/2024 at 13:00, 11 minutes ago

NioCorp Provides Preliminary Financial Results for the Three Months Ended September 30, 2024
Published on 11/08/2024 at 13:00, 11 minutes ago

Velocity One Signs Merger Agreement With EMCORE (EMKR)
Published on 11/08/2024 at 12:30, 41 minutes ago

Jaguar Mining Reports Financial Results for the Third Quarter 2024

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 12:31, 40 minutes ago

Original-Research: ORBIS SE (von GSC Research GmbH): Kaufen
Published on 11/08/2024 at 12:30, 41 minutes ago

Holding(s) in Company
Published on 11/08/2024 at 12:25, 46 minutes ago

freenet Executive Board formulates financial ambition until 2028 - EBITDA and free cash flow to grow significantly
Published on 11/08/2024 at 12:11, 1 hour ago

PNE AG selected by the European Commission for funding a project to produce hydrogen
Published on 11/08/2024 at 12:01, 1 hour 9 minutes ago

EQS-Adhoc: Borussia Dortmund reports preliminary figures for the first quarter (Q1) of the 2024/2025 financial year

Les Echos

Published on 11/08/2024 at 12:32, 39 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:32, 39 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 56 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 56 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 5 hours 11 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024

View all LES ECHOS COMFI WIRE